Tuesday, February 18, 2014 5:09:01 PM
Friday morning’s talks were exceptional, and included genomics heavy-hitters Dick McCombie and Gene Myers — both scientists who were truly influential in sequencing the human genome so many years ago. They have kept pushing boundaries, and their talks were fascinating.
Cold Spring Harbor Laboratory’s McCombie offered a presentation based on a late-breaking abstract showing the importance of de novo assembly — rather than resequencing, which can miss structural differences — using SMRT® Sequencing. He showed data from genome sequences of two strains of yeast (S. cerevisiae and S. pombe), both of which were generated using P5-C3 chemistry with BluePippin™ size selection from Sage Science. For the first strain, 15 of 16 chromosomes assembled into single contigs, with the final chromosome represented in two contigs. For S. pombe, one chromosome and the mitochondrial genome came together into individual contigs, while the other two chromosomes were split into two contigs each. McCombie’s team also worked with the Arabidopsis data set released by PacBio and compared it to an Illumina® sequencing-based assembly of the same plant. Contig N50 increased from 65 Kb with the MiSeq® platform to 8.4 Mb with the PacBio® platform. Finally, he showed data from a rice genome sequenced for him by PacBio. (He told attendees he had to contract the project out since his own PacBio RS II was running at capacity.) The mean read length was 10 Kb and the longest read produced was more than 54 Kb, earning McCombie the award for longest read presented at the conference.
Gene Myers, who recently joined the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden, Germany, said that PacBio long reads had reinvigorated his excitement about genome assembly with the promise of being able to produce reference-quality genomes. Myers has developed a tool called Dazzler (the Dresden Azzembler) that significantly accelerates the process of assembling PacBio sequence data. Dazzler works by scrubbing data prior to assembly in order to make the entire process more efficient; Myers reported a comparison of the human genome data set we just released showing a 36-fold speedup over BLASR. The tool can fully assemble an E. coli genome from PacBio reads on a regular laptop in just 10 minutes.
Later in the day, our CSO Jonas Korlach gave a talk showcasing the Iso-Seq™ method for full isoform characterization using SMRT Sequencing. He showed papers from the laboratories of Mike Snyder and Wing Wong, both at Stanford, who used PacBio long reads to fully analyze transcriptomes. Even in well-studied cell lines, Korlach noted, scientists were finding novel transcript isoforms and even novel genes thanks to information provided in these long reads. He also spoke about a metagenomics project looking at a mock human microbiome data set from NIAID, in which SMRT Sequencing was able to fully resolve more than half of the organisms in the community and get the rest into assemblies of a few contigs. The project also resolved all plasmids and yielded methylome data for the microbiome.
The evening session on genomic technologies development featured two more PacBio users. David Wheeler from Baylor’s Human Genome Sequencing Center presented sequence data for tumor/normal pairs; his group is generating 10x coverage for tumors and 5x for the matched normal tissue. He focused on structural rearrangements such as tandem duplications and said that many of these elements were driven by the movement of repeat regions around the genome. They could clearly be resolved using the PacBio technology along with two new algorithms from Adam English called Honey-tails and Honey-spots. In the other presentation, Sean McGrath from the Genome Institute at Washington University used SMRT Sequencing for gene isoform identification and prediction. His data from a cancer cell line and from a hookworm showed the ability of PacBio sequencing to identify more genes than short-read technologies had been able to identify, and also preserved the 5’ and 3’ UTR information in many cases. http://blog.pacificbiosciences.com/2014/02/agbt-day-3-highlights-single-contigs.html?utm_content=buffer7a41f&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer
Recent PACB News
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:17:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:07:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:17:12 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM